Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: A clinical practice guideline

•  The baseline risk of developing prostate cancer of any stage is likely higher than that of the general population (estimated at about 51 per 1000 men diagnosed), and

Flexible sigmoidoscopy Randomized trial to investigate whether screening methods used to detect prostate, lung, colon, rectal, or ovarian cancer can reduce deaths from these

However, adequate bowel prepara- tion is not obtained as easily with enemas as with oral for- mulations used for full colonoscopy cleansing, and the adenoma detection at

Patients (n = 300) over the age of 18 years, with a recent diagnosis of breast cancer, colorectal cancer, lymphoma, prostate cancer or testicle cancer and scheduled for ad-

In this randomized trial, the participation was higher and more colorectal cancers and advanced adenomas were detected after three rounds of fecal immunochemical testing, compared to

When it comes to colorectal cancer (CRC), randomised trials of screening with the faecal occult blood test (FOBT) have shown that such screening reduces CRC incidence

We have just finished a colorectal screening trial in Norway (1) and there- fore read the baseline findings from the Italian large-scale flexible sigmoidosco- py screening

In conclusion, the performance of a single spot from one stool sample using the PhiCal test in colorectal screening was poorer than a single screening round with FlexSure OBT